
Sign up to save your podcasts
Or


Summary
In this episode of the Talking Biotech podcast, Dr. Kevin Folta interviews Dr. Robert Tarone, a retired scientist with extensive experience in cancer statistics and experimental design. They discuss the controversial IARC monograph that classified glyphosate as a probable human carcinogen, the flaws in the evaluation process, and the implications of this classification on legal actions against glyphosate manufacturers. Dr. Tarone critiques the evidence used by IARC, emphasizing the lack of credible data linking glyphosate to cancer, and highlights the importance of rigorous scientific methodology in evaluating such claims.
By Colabra4.8
273273 ratings
Summary
In this episode of the Talking Biotech podcast, Dr. Kevin Folta interviews Dr. Robert Tarone, a retired scientist with extensive experience in cancer statistics and experimental design. They discuss the controversial IARC monograph that classified glyphosate as a probable human carcinogen, the flaws in the evaluation process, and the implications of this classification on legal actions against glyphosate manufacturers. Dr. Tarone critiques the evidence used by IARC, emphasizing the lack of credible data linking glyphosate to cancer, and highlights the importance of rigorous scientific methodology in evaluating such claims.

32,245 Listeners

6,956 Listeners

30,708 Listeners

43,588 Listeners

9,209 Listeners

4,020 Listeners

2,057 Listeners

604 Listeners

758 Listeners

3,660 Listeners

12,138 Listeners

817 Listeners

6,442 Listeners

113,300 Listeners

4,171 Listeners